• Introduction• The proof‐of‐concept in vivo: the cell, the read‐out and the animal model‐The
CEPC: Still a putative cell‐Do CEPCs play an essential role in vascular (patho) physiology …

Long-term diabetes increases the likelihood of developing secondary damage to numerous
systems, and these complications represent a substantial cause of morbidity and mortality …

Objectives: This study sought to assess of the mobilization of nonhematopoietic very small
embryonic-like stem cells (VSELs) in acute myocardial infarction (MI). Background: Acute MI …

To understand and promote vascular health, we must reduce the aggression to the vessel
wall and enhance the physiologic mechanisms leading to restoration of vessel wall function …

OBJECTIVES: Metabolic syndrome (MetS) associates with endothelial dysfunction and a
high risk of cardiovascular events and death. Circulating progenitor cells have been shown …

OBJECTIVE: We sought to directly compare the effects of type 1 and type 2 diabetes on
postischemic neovascularization and evaluate the mechanisms underlying differences …

Background Therapeutic potential was evaluated in a rat model of myocardial infarction
using nanofiber-expanded human cord blood derived hematopoietic stem cells …

Background—A common variant at chromosome 9p21 (tagged by the rs1333049 or
rs10757278 single-nucleotide polymorphism) is strongly associated with myocardial …

Objective: To investigate whether adiposity influences endothelial progenitor cell (EPC)
number and colony-forming capacity. Design: Cross-sectional study of normal weight …

The stem cell therapy for treating ischemic diseases is promising; however, the limited
availability and compromised quality of progenitor cells in aged and diseased patients limit …